心脑血管病防治2024,Vol.24Issue(7) :40-43.DOI:10.3969/j.issn.1009-816x.2024.07.008

高血压与幽门螺杆菌感染和维生素D缺乏共病研究进展

Progress in the study of hypertension with co-morbidities of Helicobacter pylori infection and vitamin D deficiency

冯展 暴一众 余利芳 饶远权
心脑血管病防治2024,Vol.24Issue(7) :40-43.DOI:10.3969/j.issn.1009-816x.2024.07.008

高血压与幽门螺杆菌感染和维生素D缺乏共病研究进展

Progress in the study of hypertension with co-morbidities of Helicobacter pylori infection and vitamin D deficiency

冯展 1暴一众 2余利芳 2饶远权2
扫码查看

作者信息

  • 1. 310053 杭州,浙江中医药大学;310013 杭州,浙江医院
  • 2. 310013 杭州,浙江医院
  • 折叠

摘要

近年来,幽门螺杆菌感染在高血压患者的研究较多,发现幽门螺杆菌感染与高血压间存在关联,且治疗幽门螺杆菌感染对高血压的改善具有积极作用.维生素D是人体必需的营养素,它与骨骼代谢、钙磷平衡及心血管疾病密切相关.近期研究显示,血清维生素D水平与高血压间存在显著的相关性,维生素D的补充对高血压患者具有潜在的治疗价值.本文就幽门螺杆菌感染和维生素D缺乏与高血压的流行情况、国内外研究现状及其共病机制进行综述.

Abstract

In recent years,many studies on Helicobacter pylori infection in hypertensive patients have found that there is a correlation between Helicobacter pylori infection and hypertension,and the treatment of Helicobacter pylori infection has a positive effect on the improvement of hypertension.Vitamin D is an essential nutrient for the human body,which is closely related to bone metabolism,calcium and phosphorus balance and cardiovascular disease.Recent studies suggest that there is a significant correlation between serum vitamin D levels and hypertension,and vitamin D supplementation has potential therapeutic value in hypertensive patients.This article reviews the prevalence of Helicobacter pylori infection,vitamin D deficiency and hypertension,research status at home and abroad,and the mechanism of comorbidity.

关键词

高血压/幽门螺杆菌/血清维生素D/共病/治疗策略

Key words

Hypertension/Helicobacter pylori/Serum vitamin D/Co-morbidities/Treatment strategies

引用本文复制引用

出版年

2024
心脑血管病防治
浙江省心脑血管病防治办公室,浙江省预防医学会,浙江医院

心脑血管病防治

CSTPCD
影响因子:0.638
ISSN:1009-816X
段落导航相关论文